Impact of Burden on Granulocyte Clearance of Bacteria in a Mouse Thigh Infection Model
Authors:
- 1 October 2010
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (10) , 4368-4372
Abstract
We wished to delineate granulocytes' impact on the clearance of different bacterial burdens of Pseudomonas aeruginosa and Staphylococcus aureus in a granulocyte-replete mouse thigh infection model. A mouse thigh model was employed. Bacterial challenges from 10 5 to 3 × 10 7 CFU ( S. aureus ) and from 3 × 10 4 to 3 × 10 8 CFU ( P. aeruginosa ) were injected into murine posterior thighs. Organism quantitation was at baseline, 2 h ( Pseudomonas only), and 24 h. A Michaelis-Menten population model was fit to the data for each organism. Breakpoints for microbial containment by granulocytes were identified. Bacterial burdens exceeding that breakpoint value resulted in organism multiplication. The Michaelis-Menten model fit the data well. For P. aeruginosa , the observed-predicted plot had a regression equation that explained over 98% of the variance ( P ≪ 0.001). For S. aureus , this relationship explained greater than 94% of the variance ( P ≪ 0.001). Maximal growth rate constants, maximal population burdens, and the bacterial loads at which granulocytes killed if half-saturated were not different. The kill rate constant for P. aeruginosa was almost 10 times that of S. aureus . Bacterial kill by granulocytes is saturable. No difference between saturation points of different isolates was seen. A higher bacterial burden means an increasing reliance on chemotherapy to drive bacterial clearance.Keywords
This publication has 15 references indexed in Scilit:
- Pharmacodynamics of Levofloxacin in a Murine Pneumonia Model of Pseudomonas aeruginosa Infection: Determination of Epithelial Lining Fluid TargetsAntimicrobial Agents and Chemotherapy, 2009
- Identifying Exposure Targets for Treatment of Staphylococcal Pneumonia with CeftobiproleAntimicrobial Agents and Chemotherapy, 2009
- Use of Pharmacokinetics and Pharmacodynamics in a Failure Analysis of Community‐Acquired Pneumonia: Implications for Future Clinical Trial Study DesignClinical Infectious Diseases, 2008
- Historical and Regulatory Perspectives on the Treatment Effect of Antibacterial Drugs for Community‐Acquired PneumoniaClinical Infectious Diseases, 2008
- In Vivo Pharmacodynamics of Ceftobiprole against Multiple Bacterial Pathogens in Murine Thigh and Lung Infection ModelsAntimicrobial Agents and Chemotherapy, 2008
- A Diabetic Man with Abdominal Pain: (Answer on pages 286–7)Clinical Infectious Diseases, 2008
- High Pneumococcal DNA Loads Are Associated With Mortality in Malawian Children With Invasive Pneumococcal DiseaseThe Pediatric Infectious Disease Journal, 2007
- Effect of Neutropenia and Treatment Delay on the Response to Antifungal Agents in Experimental Disseminated CandidiasisAntimicrobial Agents and Chemotherapy, 2007
- Pharmacodynamics of the New Fluoroquinolone Gatifloxacin in Murine Thigh and Lung Infection ModelsAntimicrobial Agents and Chemotherapy, 2002
- Pharmacodynamics of Daptomycin in a Murine Thigh Model of Staphylococcus aureus InfectionAntimicrobial Agents and Chemotherapy, 2001